Ponzify Files Its S-1

The brilliant John Flowers got a hold of the S-1 registration filing for this summer’s hottest IPO and posted it to McSweeneys…

THE OFFERING

Ponzify, Inc., is offering 15,000,000 shares of its Class A stock. Several times, in fact. Ask enough questions, we’ll let you in on the super secret Class B voting shares. Threaten to go to the SEC, and we’ll meet you near the airport. Just to talk.

We anticipate the initial public offering price of our Class A common stock will be between $35 and $42 per share. Mind you, the bank we hired to underwrite this transaction is privately telling its other clients something entirely different. Something about a guaranteed swing in the stock price and a big pay day for insiders. Sounds sweet. Wish we could get in on that

We expect to list our Class A common stock under the symbol PNZI.

Get up to speed here:

Prospectus for Silicon Valley’s Next Hot Tech IPO, Where Nothing Could Possibly Go Wrong. (McSweeneys.net)

 

 

 

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Wealthcast Media, an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. Investments in securities involve the risk of loss. For additional advertisement disclaimers see here: https://www.ritholtzwealth.com/advertising-disclaimers

Please see disclosures here.

What's been said:

Discussions found on the web
  1. immediate edge review commented on Sep 29

    … [Trackback]

    […] Information on that Topic: thereformedbroker.com/2012/06/06/ponzify-files-its-s-1/ […]

  2. Exotic Pets for Sale commented on Oct 13

    … [Trackback]

    […] Info on that Topic: thereformedbroker.com/2012/06/06/ponzify-files-its-s-1/ […]

  3. Online Timmernabben Dating commented on Nov 09

    … [Trackback]

    […] Information on that Topic: thereformedbroker.com/2012/06/06/ponzify-files-its-s-1/ […]

  4. Philips 65PUS7120/12 manuals commented on Jan 20

    … [Trackback]

    […] Find More here to that Topic: thereformedbroker.com/2012/06/06/ponzify-files-its-s-1/ […]

  5. Digital Transformation commented on Feb 05

    … [Trackback]

    […] Here you can find 43834 more Information on that Topic: thereformedbroker.com/2012/06/06/ponzify-files-its-s-1/ […]